Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-14-040694
Filing Date
2014-05-21
Accepted
2014-05-21 15:16:14
Documents
1
Period of Report
2014-05-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4793
  Complete submission text file 0001104659-14-040694.txt   6147
Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Issuer) CIK: 0001544227 (see all company filings)

EIN.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVASCIENCE, INC. 41 LINSKEY WAY, LEVEL B CAMBRIDGE MA 02142
Business Address
Dipp Michelle (Reporting) CIK: 0001551614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35890 | Film No.: 14860534